エルレアダ を前立腺がん治療薬としてFDAが承認
ERLEADA™ (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Granted U.S. FDA Approval for the Treatment of Patients with Non-Metastatic Castration-Resistant Prostate CancerFebruary 14, 2018 » Janssen, Prostate cancer